Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
---|---|---|---|---|
122940 | E-4031 | 113559-13-0 | 98% | |
E-4031 is a benzenesulfonamide antiarrhythmic agent; blocks the ATP-sensitive potassi | ||||
122935 | (2-(Ethoxycarbonyl)furan-3-yl)boronic acid | 1150114-62-7 | 98% | |
Coming soon! | ||||
122932 | Eptifibatide | 188627-80-7 | 98% | |
Eptifibatide is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class. | ||||
122841 | Eniporide | 176644-21-6 | 98% | |
Coming soon! | ||||
122811 | Enasidenib | 1446502-11-9 | 98% | |
Enasidenib is a oral potent, selective, reversible inhibitor of mutant IDH2. | ||||
121413 | Elagolix | 834153-87-6 | 98% | |
Elagolix is a Gonadotropin-Releasing Hormone (GnRH) Antagonist. | ||||
5121008 | ethyl 5-chloro-7-nitro-1H-indole-2-carboxylate | 91119-27-6 | 98% by HPLC | |
ethyl 5-chloro-7-nitro-1H-indole-2-carboxylate,CAS#91119-27-6 | ||||
120411 | Enoxacin | 74011-58-8 | 98% | |
Coming soon! | ||||
120112 | EPZ011989 | 1598383-40-4 | 98% | |
EPZ011989 is a potent, selective orally bioavailable EZH2 inhibitor with Ki < 3 nM | ||||
5112801 | Elafibranor (GFT505) | 923978-27-2 | ≧98.0% | |
Elafibranor, also known as GFT-505, is a dual PPARα/δ agonist. Elafibranoris curren | ||||
111909 | ENMD-2076 | 934353-76-1 | 98% | |
ENMD-2076 has selective activity against Aurora A and Flt3 with IC50 of 14 nM and 1.8 | ||||
111004 | Eliprodil | 119431-25-3 | 98% | |
Eliprodil is a non-competitive NR2B-NMDA receptor antagonist(IC50=1 uM), less potent | ||||
110209 | Ethyl 4,6-dichloropyridazine-3-carboxylate | 679406-03-2 | 98% | |
Coming soon! | ||||
102615 | EHop-016 | 1380432-32-5 | 98% | |
EHop-016 is a novel potent and selective inhibitor of Rac GTPase; inhibits Rac1 activ | ||||
102608 | 4EGI-1 | 315706-13-9 | 98% | |
4EGI-1 is a cell-permeable hydrazone compound that reversibly binds eukaryotic transl | ||||
102602 | EHT 1864 | 754240-09-0 | 98% | |
EHT 1864 is a small molecule inhibitor of Rac1 signaling; modulate _gamma_-Secretase- | ||||
101920 | Epirubicin hydrochloride | 56390-09-1 | 98% | |
Coming soon! | ||||
100504 | Entrectinib(RXDX-101) | 1108743-60-7 | 98% by HPLC | |
Entrectinib (RXDX-101) is a selective inhibitor for all three TRK receptor tyrosine k | ||||
92209 | ethyl 1-amino-2-ethenylcyclopropane-1-carboxylate | 787548-29-2 | 98% | |
Coming soon! | ||||
91807 | Ethyl 1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarboxylate | 1257213-52-7 | 98% | |
Coming soon! | ||||
91707 | Ethyl 3-(4-fluorophenyl)-1H-pyrazole-5-carboxylate | 866588-11-6 | 98% | |
Coming soon! | ||||
91413 | ethyl 2-amino-5-oxo-7-propan-2-ylchromeno[2,3-b]pyridine-3-carboxylate | 68301-99-5 | 98% | |
The related API: AmoxanoxThe related intermediates: 4-oxo-6-propan-2-ylchromene-3-car | ||||
90104 | Ethyl L-pyroglutamate | 7149-65-7 | 98% | |
Coming soon! | ||||
82729 | (E)-3α-hydroxy-6-ethylidene-7-keto-5β-cholan-24-oic acid | 1516887-33-4 | 98% | |
Coming soon! | ||||
82710 | 3-(4-ethoxycarbonyl-5-methyl-1H-pyrrol-3-yl)propanoic acid | 38664-16-3 | 98% | |
Coming soon! | ||||
82709 | Etoricoxib | 202409-33-4 | 98% | |
Etoricoxib selectively inhibited COX-2 in human whole blood assays in vitro, with an | ||||
82603 | Ertugliflozin | 1210344-57-2 | 98% | |
Ertugliflozin is a potent and selective inhibitor of the sodium-dependent glucose cot | ||||
81312 | Ethyl (E)-3,5-dihydroxy-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-hept-6-enoate | 172336-32-2 | 98% | |
Related API & intermediates:Cas#147526-32-7 Pitavastatin CalciumCas# 24922-02-9 E | ||||
81311 | Ethyl (E)-7-[4-(4'-fluorophenyl)-2-(cyclopropyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptenoate | 148901-69-3 | 98% | |
Related API & intermediates:Cas#147526-32-7 Pitavastatin CalciumCas# 24922-02-9 E | ||||
81310 | (E)-3-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl-2-propenal | 148901-68-2 | 98% | |
Related API & intermediates:Cas#147526-32-7 Pitavastatin CalciumCas# 24922-02-9 E |
Overnight Delivery
Fast & Safe Delivery Worldwide
Safety and Security
Intimate Service
Copyright 2015-2022 武汉永璨生物科技有限公司 版权所有 | 鄂ICP备17005301号-1